STRS Ohio’s MediciNova MNOV Stock Holding History

STRS Ohio’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-9,500	Closed	-$57.2K	–	1910
2016 Q4	$57K	Hold	9,500	–	–	﹤0.01%	1778
2016 Q3	$71K	Sell	9,500 -400	-4%	-$2.69K	﹤0.01%	1716
2016 Q2	$74K	Buy	+9,900	New	+$71.6K	﹤0.01%	1718

Other funds holding MNOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

STRS Ohio's MNOV Position: Q1 2017 in Review

STRS Ohio sold out of MediciNova (MNOV) in Q1 2017, closing a stake of 9,500 shares — an estimated $57.2K sold.

STRS Ohio first reported a position in MNOV in Q2 2016 and held it in 3 quarters. The position peaked at $74K in Q2 2016. 45 funds tracked by Wall St. Rank hold MNOV as of Q1 2017.

STRS Ohio reported no remaining MediciNova position as of Q1 2017 after selling out during the quarter.
STRS Ohio sold 9,500 MediciNova shares in Q1 2017, an estimated $57.2K.
STRS Ohio first reported a position in MediciNova in Q2 2016 and held it in 3 quarters.
STRS Ohio's MediciNova position peaked at $74K in Q2 2016.
45 funds tracked by Wall St. Rank held MediciNova as of Q1 2017.

Based on STRS Ohio's 13F filing for Q1 2017, filed 26 Apr 2017.